lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
287 rows where filing_period = "second_quarter", filing_year = 2019 and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2297602 | ACT FOR NIH cd54f05b-ba05-491e-99c3-97957ad10461 | 2T | ACT FOR NIH | 401103441 | ACT FOR NIH | 2019 | second_quarter | MED | NIH Appropriations | HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2019-05-31T11:42:18.147000-04:00 | ||
| 2298247 | THE CONSILIO GROUP e3f587e9-f36d-4a78-8359-44ac5cf49721 | Q2 | THE CONSILIO GROUP | 400374717 | MADEN TECH CONSULTING, INC. | 2019 | second_quarter | MED | Infrastructure rebuilding. | Federal Emergency Management Agency (FEMA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 6000 | 0 | 0 | 2019-06-28T12:14:37.213000-04:00 | |
| 2298335 | AUBURN HEALTH STRATEGIES, LLC 819a5272-7215-43cf-bce4-069a7f328743 | Q2 | AUBURN HEALTH STRATEGIES, LLC | 292697 | API GROUP (FORMERLY KNOWN AS API FOOD QUALITY INC ) | 2019 | second_quarter | MED | quality of laboratory testing | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2019-07-01T09:10:04.787000-04:00 | ||
| 2298340 | AUBURN HEALTH STRATEGIES, LLC 81a98e17-518f-4bea-9ffe-d921dc0e6e6d | Q2 | AUBURN HEALTH STRATEGIES, LLC | 292697 | NEUROTECH, LLC | 2019 | second_quarter | MED | EEG monitoring | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2019-07-01T09:15:07.117000-04:00 | ||
| 2298345 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) eacf9798-8a62-4d2c-9a39-57085ddf0a8a | Q2 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | 400361684 | PPLA | 2019 | second_quarter | MED | Pharmaceutical labeling | Food & Drug Administration (FDA) | 18700 | 0 | 0 | 2019-07-01T09:23:10.647000-04:00 | |
| 2298346 | AUBURN HEALTH STRATEGIES, LLC f69dd1d6-6334-42c9-bbf2-b5005580aee1 | 2T | AUBURN HEALTH STRATEGIES, LLC | 292697 | API GROUP (FORMERLY KNOWN AS API FOOD QUALITY INC ) | 2019 | second_quarter | MED | quality of laboratory testing | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2019-07-01T09:24:11.303000-04:00 | ||
| 2298361 | FRANCIS EDWARD & CRONIN, INC. 88a935ec-102c-404f-bd6e-2be7561288d0 | Q2 | FRANCIS EDWARD & CRONIN, INC. | 311314 | CURE ALZHEIMER'S FUND | 2019 | second_quarter | MED | Issues and legislation related to Alzheimer's disease research | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE | 20000 | 0 | 0 | 2019-07-01T10:24:21.030000-04:00 | |
| 2298363 | FRANCIS EDWARD & CRONIN, INC. 0b04ce92-889f-47bd-99e2-1350631afc23 | Q2 | FRANCIS EDWARD & CRONIN, INC. | 311314 | PATH DECISION SUPPORT SOFTWARE, LLC | 2019 | second_quarter | MED | Issues and legislation related to diabetes treatment and diagnosis | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2019-07-01T10:26:22.687000-04:00 | ||
| 2298541 | MR. BRIAN KELLY 09ae6202-886a-46ac-b516-0ca4d33151ba | Q2 | MR. BRIAN KELLY | 40024191 | INTELLIA THERAPEUTICS | 2019 | second_quarter | MED | WHO Gene Editing Summit | Defense Advanced Research Projects Agency (DARPA),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,White House Office | 15000 | 0 | 0 | 2019-07-01T17:30:36.810000-04:00 | |
| 2298642 | AMERICAN COLLEGE OF CLINICAL PHARMACY 654ca888-9145-4b8c-b9af-df6f5c31057f | Q2 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2019 | second_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 144981 | 0 | 0 | 2019-07-02T10:25:36.093000-04:00 | |
| 2298666 | FEDERAL SOLUTIONS, LLC 96df5882-16f9-4815-a1fa-25f4ecd28d5a | Q2 | FEDERAL SOLUTIONS, LLC | 311371 | MISSISSIPPI STATE UNIVERSITY | 2019 | second_quarter | MED | Labor/HHS/Education Appropriations: Provisions relating to disease research. | Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 50000 | 0 | 0 | 2019-07-02T10:48:42.547000-04:00 | |
| 2298772 | LOCKRIDGE, GRINDAL, NAUEN, PLLP 19b77f43-dd2b-4ac6-baca-40a8f634cca1 | Q2 | LOCKRIDGE, GRINDAL, NAUEN, PLLP | 23053 | HENNEPIN COUNTY MEDICAL CENTER | 2019 | second_quarter | MED | FY2020 Authorizations, Appropriations, and Budget Policy | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2019-07-02T11:55:25.853000-04:00 | ||
| 2298893 | NATURAL RESOURCE RESULTS LLC 39e82610-8b1d-4405-ab63-af50fd26c33d | Q2 | NATURAL RESOURCE RESULTS LLC | 321555 | SHINE MEDICAL TECHNOLOGIES | 2019 | second_quarter | MED | Support budget and approps for grants to cooperatives on medical isotope MO-99 production facility. | Energy, Dept of,HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 10000 | 0 | 0 | 2019-07-02T15:18:33.500000-04:00 | |
| 2298946 | AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION 81093bec-49c1-478f-a29c-f838c6f65ccc | Q2 | AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION | 401103437 | AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION | 2019 | second_quarter | MED | Support Preserving Patient Access to Compounded Medications | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 0 | 0 | 2019-07-02T16:04:54.367000-04:00 | ||
| 2299239 | REPUBLIC CONSULTING, LLC fb931655-b239-4d2d-9578-cabb0e348eb3 | Q2 | REPUBLIC CONSULTING, LLC | 401016871 | IQVIA | 2019 | second_quarter | MED | Monitor Data and Science policy. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2019-07-03T12:19:29.370000-04:00 | |
| 2299244 | REPUBLIC CONSULTING, LLC d267212c-dc2b-4ffe-b706-5484bfb3431f | 2A | REPUBLIC CONSULTING, LLC | 401016871 | IQVIA | 2019 | second_quarter | MED | Monitor Data and Science policy. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2019-07-03T12:31:31.197000-04:00 | |
| 2299315 | NEOGENOMICS LABORATORIES 3a7dbbc8-a313-4d21-bafd-19891a910489 | Q2 | NEOGENOMICS LABORATORIES | 401105014 | NEOGENOMICS LABORATORIES | 2019 | second_quarter | MED | Diagnostic Accuracy and Innovation Act | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 52615 | 0 | 0 | 2019-07-03T13:58:03.927000-04:00 | |
| 2299424 | MARSHALL BRACHMAN 4cf3c8b4-4980-4c2b-ba7e-bc5fbc05dbac | Q2 | MARSHALL BRACHMAN | 6848 | BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM | 2019 | second_quarter | MED | support funding for medical research programs | HOUSE OF REPRESENTATIVES,SENATE | 33000 | 0 | 0 | 2019-07-03T17:22:55.903000-04:00 | |
| 2299514 | HOLLAND & KNIGHT LLP 84c0b68d-318c-48af-861f-8e7b3a4165e0 | Q2 | HOLLAND & KNIGHT LLP | 18466 | PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION | 2019 | second_quarter | MED | Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; House and Senate FY 2020 Ag-FDA Appropriations bills and reports (H.R. 3164); Sunscreen use in schools; Sunscreen provisions in H.R. 3443, Over-the-Counter Monograph Safety, Innovation and Reform Act of 2019; Issues related to state bans on sunscreen ingredients. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2019-07-05T10:54:07-04:00 | |
| 2299711 | OTT BIELITZKI & O'NEILL PLLC 3e36c854-4974-4979-b495-eeba631def86 | Q2 | OTT BIELITZKI & O'NEILL PLLC | 401103584 | BIOPORTO DIAGNOSTICS A/S | 2019 | second_quarter | MED | Educating officials about a health care diagnostic tool. | Agriculture, Dept of (USDA),Defense, Dept of (DOD),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2019-07-06T06:23:02.090000-04:00 | |
| 2299789 | AMERICAN GASTROENTEROLOGICAL ASSOCIATION 435b7581-7091-4095-8cec-bea02281ae75 | Q2 | AMERICAN GASTROENTEROLOGICAL ASSOCIATION | 59650 | AMERICAN GASTROENTEROLOGICAL ASSOCIATION | 2019 | second_quarter | MED | Lobbied for a $2 billion increase in funding for the NIH. Also lobbied for increased funding for the VA's medical and prosthetic research program as well as increased funding for the DoD's Peer-Reviewed Cancer Research Program. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2019-07-08T09:59:30.437000-04:00 | |
| 2299845 | KUTAK ROCK LLP 2098e22b-5232-4258-910f-fd546e965b7d | Q2 | KUTAK ROCK LLP | 21962 | NE ENTERPRISES | 2019 | second_quarter | MED | Reauthorization of Pandemic and All Hazards Preparedness Act and related matters | 20000 | 0 | 0 | 2019-07-08T11:50:07.027000-04:00 | ||
| 2299867 | O'NEILL AND ASSOCIATES b4955ceb-fe7c-48ca-bff6-c919fca3afd8 | Q2 | O'NEILL AND ASSOCIATES | 73134 | POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) | 2019 | second_quarter | MED | Medical | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2019-07-08T12:31:21.937000-04:00 | |
| 2299875 | O'NEILL AND ASSOCIATES 4ab3af91-b8f1-45f4-8850-6b5a44381e52 | Q2 | O'NEILL AND ASSOCIATES | 73134 | ANALOGIC | 2019 | second_quarter | MED | Medical Technology | HOUSE OF REPRESENTATIVES,SENATE | 7500 | 0 | 0 | 2019-07-08T12:42:28.940000-04:00 | |
| 2300118 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 6d55ba03-3546-4909-813a-9d2bd82a03c0 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ASSOCIATION FOR MOLECULAR PATHOLOGY | 2019 | second_quarter | MED | Regulation of laboratory diagnostics HR 5062, Advancing Access to Precision Medicine Act No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-07-09T10:07:29.647000-04:00 | |
| 2300122 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8b9b8850-3a43-4f38-9a27-5aa16c2e8d26 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ENDOCRINE SOCIETY | 2019 | second_quarter | MED | Research in Endocrinology, Standardization of Hormone Testing | Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2019-07-09T10:16:31.587000-04:00 | |
| 2300192 | CAPITOL IMPACT, LLC f103fffe-2669-4d83-87fc-a0c9954ddd15 | Q2 | CAPITOL IMPACT, LLC | 284471 | THE LIVINGSTON GROUP, LLC (RUSH UNIVERSITY MEDICAL CENTER) | 2019 | second_quarter | MED | Congressional Letter to increase NIH funding. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-07-09T11:42:14.610000-04:00 | |
| 2300524 | THORN RUN PARTNERS 37bd800a-4fe3-4c13-9ae0-cd547c600c30 | Q2 | THORN RUN PARTNERS | 400534596 | GLAUKOS CORPORATION | 2019 | second_quarter | MED | Issues related to implementation of the 21st Century Cures Act (P.L.114-255). | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2019-07-09T16:43:21.893000-04:00 | |
| 2300615 | MICHAEL N. MCCARTY LAW OFFICE PLLC cabde6a6-c765-4ed5-8cdf-b81048642efd | Q2 | MICHAEL N. MCCARTY LAW OFFICE PLLC | 401104300 | AMERICAN MEDICAL TECHNOLOGISTS | 2019 | second_quarter | MED | Appropriations for harmonization of diagnostic laboratory test results; Appropriations for CDC initiative to establish pediatric reference intervals for clinical diagnostic testing; proposed legislation to establish clinical laboratory workforce development initiatives under the Public Health Service Act and other potential legislative vehicles; prospective legislation to regulate in vitro clinical diagnostic tests, including laboratory-developed tests. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2019-07-09T19:39:10.067000-04:00 | |
| 2300760 | MCDERMOTT+ LLC 61fdeefa-ccb4-4aff-a1da-78c392e55372 | Q2 | MCDERMOTT+ LLC | 401103287 | COALITION FOR 21ST CENTURY MEDICINE | 2019 | second_quarter | MED | Issues concerning regulation of laboratory-developed tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 40000 | 0 | 0 | 2019-07-10T10:27:44.263000-04:00 | |
| 2300908 | TCH GROUP, LLC c7f07ff0-b691-448d-a9a6-b4787ddc477f | Q2 | TCH GROUP, LLC | 51478 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2019 | second_quarter | MED | FY 20 State Foreign Operations Subcommittee Appropriations bills (HR 2740 and HR 2839). Specifically, continued Federal funding under USAID for AIDS vaccine research and development. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-07-10T12:43:17.780000-04:00 | |
| 2301197 | THORN RUN PARTNERS f18371a2-7436-4c74-b640-d3a1790f7565 | Q2 | THORN RUN PARTNERS | 400534596 | BIOGEN | 2019 | second_quarter | MED | Issues dealing with newborn screening. Issues dealing with Alzheimer's treatments. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2019-07-10T17:20:06.900000-04:00 | |
| 2301214 | RAY C CULVER III 8b7cb98c-67de-40f7-856c-86b9b889cb03 | Q2 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2019 | second_quarter | MED | Funding for USDA ARS Human Nutrition Research Centers in FY20 Agricultural Appropriations (H.R.3055). | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2019-07-10T18:11:19.420000-04:00 | |
| 2301460 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 29da3f0b-37ae-49ac-a1f3-be14223c62d9 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | TUBEROUS SCLEROSIS ALLIANCE | 2019 | second_quarter | MED | HR 2968, Department of Defense Appropriations Act 2020 HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020 Peer-Reviewed Medical Research Program | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2019-07-11T11:53:35.437000-04:00 | |
| 2301472 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 804ef0a7-76f5-4382-a152-ac69a1ad48b6 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | FOUNDATION FOR PERIPHERAL NEUROPATHY | 2019 | second_quarter | MED | HR 2968, Department of Defense Appropriations Act 2020 HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020 | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2019-07-11T12:04:44.017000-04:00 | |
| 2301475 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 70644966-86f8-4aa9-bd5c-77908a46b6e0 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | PANCREATIC CANCER ACTION NETWORK (PANCAN) | 2019 | second_quarter | MED | cancer research at DOD and NIH HR 2968, Department of Defense Appropriations Act 2020 HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020 Peer Reviewed Medical Research | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 40000 | 0 | 0 | 2019-07-11T12:06:44.940000-04:00 | |
| 2301477 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 0e7aa66b-61ed-44f9-b062-f5fc0ad29a5a | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION | 2019 | second_quarter | MED | Research opportunities at the Department of Defense and the Centers for Disease Control HR 2968, Department of Defense Appropriations Act 2020 HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020 Defense Medical Research, NIH funding | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2019-07-11T12:08:47.580000-04:00 | |
| 2301520 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. a20727ee-506e-4a11-9570-efe45f613793 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL HEMOPHILIA FOUNDATION | 2019 | second_quarter | MED | Hemophilia research, prevention, surveillance and service programs and issues | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2019-07-11T12:48:03.180000-04:00 | |
| 2301832 | MOLNLYCKE HEALTH CARE US, LLC 15afa9a3-fe2f-4682-8585-aebb32254d4b | Q2 | MOLNLYCKE HEALTH CARE US, LLC | 401104898 | MOLNLYCKE HEALTH CARE US, LLC | 2019 | second_quarter | MED | Pursuance of approval from relevant agencies of a medical pilot program; gathering support from Congressional leaders. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2019-07-11T16:33:08.050000-04:00 | |
| 2302058 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER f839166e-2a0f-4f97-8699-73e9b3eace56 | Q2 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 312496 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 2019 | second_quarter | MED | NIH Budget, PCORI re authorization, NICHD budget, sickle cell research, CHGME, 340B, surprise billing legislation, screening and enrollment issues | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 39050 | 0 | 0 | 2019-07-12T09:53:14.490000-04:00 | |
| 2302181 | EFB ADVOCACY, LLC e539694c-1c53-4483-b554-f6c61f359577 | Q2 | EFB ADVOCACY, LLC | 401104430 | UNITED FOR MEDICAL RESEARCH | 2019 | second_quarter | MED | Funding Issues Related to the National Institutes of Health | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2019-07-12T10:45:55.747000-04:00 | |
| 2302223 | SPECTRUM PUBLIC AFFAIRS ec4a6be9-2ab5-4dd9-b231-615fd3c955d2 | 2T | SPECTRUM PUBLIC AFFAIRS | 401103271 | WESTERN MICHIGAN UNIVERSITY | 2019 | second_quarter | MED | Opioid policy and research. | Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2019-07-12T11:01:16.217000-04:00 | |
| 2302459 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 74a08e2b-eea9-4bc2-afc3-16e74401e9d9 | Q2 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH | 314055 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH | 2019 | second_quarter | MED | Support for Medical Research Funding Programs at the National Institutes of Health, the National Eye Institute, and the Department of Defense | HOUSE OF REPRESENTATIVES,SENATE | 64042 | 0 | 0 | 2019-07-12T14:03:57.613000-04:00 | |
| 2302483 | HANCE SCARBOROUGH 7c5bd5d4-6a53-46f9-b45b-3712879730d8 | Q2 | HANCE SCARBOROUGH | 17443 | TITAN PHARMACEUTICALS, INC. | 2019 | second_quarter | MED | Medicare/Medicaid drug coverage, opioid addiction policy. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2019-07-12T14:12:03.647000-04:00 | ||
| 2303301 | THE CJR GROUP, INC. 737a3f5c-8a86-4b17-b854-1a6ba09e2348 | Q2 | THE CJR GROUP, INC. | 288293 | UNIVERSITY HOSPITALS HEALTH SYSTEM | 2019 | second_quarter | MED | NIH funding, mental health initiatives | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2019-07-15T11:29:59.117000-04:00 | |
| 2303429 | WAKE FOREST UNIVERSITY HEALTH SCIENCES 479234d0-538f-4c61-a9c4-5a47486c86f3 | Q2 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 6781 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2019 | second_quarter | MED | Lifting of spending caps and raising the debt ceiling discussions, VA Research funding and access; VA Missions Act implementation; FY 2020 President's Budget Request for VA Research Programs; Higher Education Act reauthorization; animal research legislation; FY 2020 President's Budget Request for Departments of Labor/HHS | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 150000 | 0 | 0 | 2019-07-15T12:29:50.040000-04:00 | |
| 2303520 | ALPINE GROUP PARTNERS, LLC. 779bee4a-42bb-4f80-a5d5-780348ec4e76 | Q2 | ALPINE GROUP PARTNERS, LLC. | 1171 | ROBOKIND | 2019 | second_quarter | MED | Issues relating to autism education and research | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2019-07-15T13:16:17.123000-04:00 | |
| 2303768 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. dc12826f-3363-4409-a808-47d781645549 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL ASSOCIATION OF EPILEPSY CENTERS | 2019 | second_quarter | MED | Research and public health programs in epilepsy. | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2019-07-15T14:58:46.683000-04:00 | |
| 2303779 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 02cfcc66-7b5e-4d09-94b7-24e94e836b00 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | AMERICAN SOCIETY OF HEMATOLOGY | 2019 | second_quarter | MED | Research in hematology | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2019-07-15T15:00:50.497000-04:00 | |
| 2304011 | INTUITIVE SURGICAL, INC. d00fe58c-7c0d-4d71-932b-3a842c80958e | Q2 | INTUITIVE SURGICAL, INC. | 400670004 | INTUITIVE SURGICAL, INC. | 2019 | second_quarter | MED | comparative effectiveness research in healthcare | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2019-07-15T16:08:14.567000-04:00 | |
| 2304051 | HACKENSACK MERIDIAN HEALTH 63c22576-d49e-4d6c-bfb5-9b493f6870c8 | Q2 | HACKENSACK MERIDIAN HEALTH | 401104109 | HACKENSACK MERIDIAN HEALTH | 2019 | second_quarter | MED | National Institutes of Health funding Behavioral health Substance abuse, opioids, and patient data | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2019-07-15T16:23:32.317000-04:00 | |
| 2304064 | AMERICA'S BLOOD CENTERS 5ada95c3-3a4d-4aad-bdd0-12253d9420fa | Q2 | AMERICA'S BLOOD CENTERS | 3834 | AMERICA'S BLOOD CENTERS | 2019 | second_quarter | MED | Value of Blood/Reimbursement Blood center testing for Babesia Bacterial risk strategies for platelets | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-07-15T16:29:36.630000-04:00 | |
| 2304475 | MAGNET STRATEGY GROUP 9630cda2-a9eb-4cc5-85e1-a60cadd3af67 | Q2 | MAGNET STRATEGY GROUP | 401104125 | MEDICAGO INC. | 2019 | second_quarter | MED | Strategies for emergency heath response, with respect to development and deployment of medical countermeasures for emerging infectious disease. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2019-07-16T09:57:07.867000-04:00 | ||
| 2304510 | SQUIRE PATTON BOGGS 87d24faa-7a42-4738-a5ce-ce4912009b5a | Q2 | SQUIRE PATTON BOGGS | 30906 | ALLIANCE FOR BIOSECURITY | 2019 | second_quarter | MED | Preparedness and response as it relates to Biosecurity. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 80000 | 0 | 0 | 2019-07-16T10:14:22.883000-04:00 | |
| 2304526 | FAEGRE DRINKER BIDDLE & REATH LLP 76c83744-e97e-4b04-aded-4fc110e3efeb | Q2 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA | 2019 | second_quarter | MED | Issues related to anti-microbial resistance and neglected tropical diseases. | 10000 | 0 | 0 | 2019-07-16T10:15:27.477000-04:00 | ||
| 2304538 | SQUIRE PATTON BOGGS 69393ca1-b9c7-4fdc-87eb-4dc76df9eed8 | Q2 | SQUIRE PATTON BOGGS | 30906 | IMPACT JOURNALS, LLC | 2019 | second_quarter | MED | National Library of Medicine publication and archive matters. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2019-07-16T10:20:33.680000-04:00 | |
| 2304567 | SQUIRE PATTON BOGGS 6e25ff4c-0436-4e68-8f92-ae3f4f9c358d | Q2 | SQUIRE PATTON BOGGS | 30906 | MOLNLYCKE HEALTH CARE US, LLC | 2019 | second_quarter | MED | Working with congressional leaders to improve pressure ulcer reimbursement and awareness and other hospital acquired conditions. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2019-07-16T10:30:45.120000-04:00 | |
| 2304581 | SQUIRE PATTON BOGGS cd5dbaf2-4de3-42b0-83ee-24a0be671221 | Q2 | SQUIRE PATTON BOGGS | 30906 | UNIVERSITY OF GEORGIA | 2019 | second_quarter | MED | Traumatic brain injury research, funding, and outreach opportunities. Research related to emerging and infectious diseases. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2019-07-16T10:34:48.653000-04:00 | |
| 2304657 | THE PETRIZZO GROUP, INC. b7670b95-5295-44bd-9f3b-c11c5c003595 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | ALLEN INSTITUTE | 2019 | second_quarter | MED | Advocated for funding of the BRAIN Initiative, Alzheimer's research full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2019-07-16T11:13:25.390000-04:00 | |
| 2305080 | ISEMAN & ASSOCIATES LLC 2a0cf943-8a71-46d1-8dcb-4e56f4f9cc37 | Q2 | ISEMAN & ASSOCIATES LLC | 401103582 | TICHENOR VENTURES, LLC | 2019 | second_quarter | MED | Monitoring biotech legislation | HOUSE OF REPRESENTATIVES,SENATE | 12500 | 0 | 0 | 2019-07-16T13:35:15.703000-04:00 | |
| 2305374 | AMERICAN PHYSICAL THERAPY ASSOCIATION 279845eb-32eb-40c0-9d00-1dc3624da761 | Q2 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 3093 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 2019 | second_quarter | MED | NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding Physical Therapist role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),Veterans Affairs, Dept of (VA),White House Office | 243000 | 0 | 0 | 2019-07-16T14:36:17.020000-04:00 | |
| 2305920 | LNE GROUP a7d363dd-6940-4cfc-8b59-7ffa9cc36b6e | Q2 | LNE GROUP | 308811 | HOSPICE OF THE WESTERN RESERVE | 2019 | second_quarter | MED | lobbied for medical issues | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 20000 | 0 | 0 | 2019-07-16T17:02:22.677000-04:00 | |
| 2306228 | LNE GROUP 9acc4fe5-cdd8-4b49-8475-a8d19e3f22ff | Q2 | LNE GROUP | 308811 | OHIOGUIDESTONE (FORMALLY KNOWN AS GUIDESTONE) | 2019 | second_quarter | MED | lobbied for medical issues | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-07-17T09:14:26.643000-04:00 | |
| 2306287 | WILLIAMS AND JENSEN, PLLC b1821fad-bbac-494f-ad5c-28012f91cd6c | Q2 | WILLIAMS AND JENSEN, PLLC | 41454 | VERTEX PHARMACEUTICALS INCORPORATED | 2019 | second_quarter | MED | General education about FDA approval policies and NIH research activities. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2019-07-17T10:01:47.023000-04:00 | |
| 2306293 | WILLIAMS AND JENSEN, PLLC 753b6ee3-c2ee-4af1-8a26-16c4a66d833a | Q2 | WILLIAMS AND JENSEN, PLLC | 41454 | SANOFI, U.S. | 2019 | second_quarter | MED | General education about FDA approval policies and NIH research activities. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2019-07-17T10:02:48.117000-04:00 | |
| 2306461 | WILLIAMS AND JENSEN, PLLC 6ece8168-9d72-43ea-b12e-81cbdfa2efbc | Q2 | WILLIAMS AND JENSEN, PLLC | 41454 | GLOBAL DOWN SYNDROME FOUNDATION | 2019 | second_quarter | MED | Support for down syndrome research funding. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 40000 | 0 | 0 | 2019-07-17T10:42:47.807000-04:00 | |
| 2306489 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 5d48294a-6613-4e7d-b836-b92ae6a7c039 | Q2 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY | 3435 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY | 2019 | second_quarter | MED | Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases | Agency for Healthcare Research & Quality (AHRQ),Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Veterans Affairs, Dept of (VA),White House Office | 42000 | 0 | 0 | 2019-07-17T10:50:00.137000-04:00 | |
| 2306528 | FAEGRE DRINKER BIDDLE & REATH LLP 4229e0c2-e2ef-464b-80bf-e0aa0174da85 | Q2 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2019 | second_quarter | MED | Public Health Programs for Infectious and Tropical Disease and Anti-Microbial Resistance; NIH Research. | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2019-07-17T10:57:12.623000-04:00 | |
| 2306546 | FAEGRE DRINKER BIDDLE & REATH LLP 8ffa59d7-8177-4363-b423-2f48115f1797 | Q2 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH | 2019 | second_quarter | MED | H.R. 6378 Pandemic All Hazards Preparedness Act Reauthorization; S. 2852 Pandemic and All Hazards Preparedness and Advancing Innovation Act; H.R. 3460 End Neglected Tropical Diseases Act; COMPETES Act Reauthorization. | HOUSE OF REPRESENTATIVES | 20000 | 0 | 0 | 2019-07-17T10:58:18.343000-04:00 | |
| 2306550 | FAEGRE DRINKER BIDDLE & REATH LLP 59c3b571-d1f0-4bab-b0c2-f5bf5606532d | Q2 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | PREECLAMPSIA FOUNDATION | 2019 | second_quarter | MED | Preeclampsia Research Issues. | Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2019-07-17T11:00:20.327000-04:00 | |
| 2306648 | WILLIAMS AND JENSEN, PLLC f768396c-0e49-44f8-9032-52df9b2ba75c | Q2 | WILLIAMS AND JENSEN, PLLC | 41454 | MT PHARMA AMERICA, INC. | 2019 | second_quarter | MED | Matters affecting access to pharmaceuticals; payment policies for drugs under Medicare Part B; Coverage of drugs under Part B and Part D. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2019-07-17T11:16:10.577000-04:00 | |
| 2306725 | ISEMAN & ASSOCIATES LLC 1a3d521a-feea-4c5f-b5dd-9c0ac01d4ea9 | Q2 | ISEMAN & ASSOCIATES LLC | 401103582 | PILLNURSE, LLC | 2019 | second_quarter | MED | Medical device funding | HOUSE OF REPRESENTATIVES,SENATE | 22500 | 0 | 0 | 2019-07-17T11:36:42.550000-04:00 | |
| 2306748 | COMMONWEALTH POLICY SOLUTIONS 80eed109-3a41-4a02-b3aa-c3105f383a48 | Q2 | COMMONWEALTH POLICY SOLUTIONS | 401105004 | TRISALUS LIFE SCIENCES | 2019 | second_quarter | MED | Medical device development for oncology, drug delivery for oncology | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2019-07-17T11:41:50.893000-04:00 | |
| 2306760 | COMMONWEALTH POLICY SOLUTIONS 05b90d45-5801-4391-a98f-baf56e12d16d | Q2 | COMMONWEALTH POLICY SOLUTIONS | 401105004 | RARE ACCESS ACTION PROJECT | 2019 | second_quarter | MED | Reimbursement for rare disease patient care | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2019-07-17T11:43:54.330000-04:00 | ||
| 2306824 | LNE GROUP 5e2d2535-a2f4-4b84-97f7-baaf0fef984d | Q2 | LNE GROUP | 308811 | PARKER HANNIFIN | 2019 | second_quarter | MED | lobbied on medical issues | HOUSE OF REPRESENTATIVES,SENATE,U.S. Coast Guard (USCG) | 80000 | 0 | 0 | 2019-07-17T11:50:10.317000-04:00 | |
| 2306862 | WASHINGTON UNIVERSITY IN ST. LOUIS 3ac67a5b-294e-48ba-8929-392e6fe9f0cf | Q2 | WASHINGTON UNIVERSITY IN ST. LOUIS | 40031264 | WASHINGTON UNIVERSITY IN ST LOUIS | 2019 | second_quarter | MED | General advocacy for NIH and other biomedical research. General support for the development of fair and effective organ transplant policies. General advocacy supporting the continued responsible utilization of research animals. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2019-07-17T11:55:17.257000-04:00 | |
| 2307061 | CARDINAL HEALTH, INC. 843aaec7-5825-4a29-a79e-853a205dce43 | Q2 | CARDINAL HEALTH, INC. | 58055 | CARDINAL HEALTH INC | 2019 | second_quarter | MED | Medical Device Tax Repeal - H.R. 2207, S. 692, Protect Medical Innovation Act of 2019 | Federal Emergency Management Agency (FEMA),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 550000 | 0 | 0 | 2019-07-17T12:35:10.180000-04:00 | |
| 2307136 | THE CORMAC GROUP, LLC a5f8dadb-ecd8-4452-8f8b-86d3d9829ced | Q2 | THE CORMAC GROUP, LLC | 66773 | KESSLER FOUNDATION | 2019 | second_quarter | MED | Appropriations, DOD, TBI research, Veterans Issues | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2019-07-17T13:01:35.890000-04:00 | |
| 2307232 | THE CORMAC GROUP, LLC bb3b55ee-dd2b-4fe1-93e9-590695bb7221 | Q2 | THE CORMAC GROUP, LLC | 66773 | HEARTFLOW, INC. | 2019 | second_quarter | MED | Medicare payment issues | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2019-07-17T13:21:11.113000-04:00 | |
| 2307455 | WILLIAMS AND JENSEN, PLLC 21d2bd5d-d296-4cf0-8c16-c1d5f6dd8f01 | Q2 | WILLIAMS AND JENSEN, PLLC | 41454 | ECRI INSTITUTE | 2019 | second_quarter | MED | General education regarding patient safety initiatives, medical product safety, and evidence-based healthcare information to improve patient care. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2019-07-17T14:04:46.587000-04:00 | |
| 2307723 | UNIVERSITY OF IOWA 70660f97-568d-4ebd-bc39-ec7ec2c45a5b | Q2 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2019 | second_quarter | MED | Support for all federal agencies that fund medical and disease research | Commerce, Dept of (DOC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2019-07-17T14:46:24.017000-04:00 | |
| 2308074 | GOLDBUG STRATEGIES LLC 5673158c-6748-43a6-9d14-30d6e97af200 | Q2 | GOLDBUG STRATEGIES LLC | 400701094 | COALITION FOR 21ST CENTURY MEDICINE | 2019 | second_quarter | MED | in vitro diagnostics, clinical laboratories, digital health regulation | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-07-17T15:52:24.810000-04:00 | |
| 2308096 | GOLDBUG STRATEGIES LLC f8d01280-2447-4da5-acea-013b7c6533d7 | Q2 | GOLDBUG STRATEGIES LLC | 400701094 | LIFE TECHNOLOGIES/THERMO FISHER | 2019 | second_quarter | MED | in vitro diagnostics, clinical laboratories, digital health regulation | Food & Drug Administration (FDA) | 0 | 0 | 2019-07-17T15:57:34.777000-04:00 | ||
| 2308103 | GOLDBUG STRATEGIES LLC 60522853-3198-49ae-869a-c20e76040d85 | Q2 | GOLDBUG STRATEGIES LLC | 400701094 | 23ANDME, INC. | 2019 | second_quarter | MED | in vitro diagnostics, clinical laboratories, digital health regulation | Food & Drug Administration (FDA) | 10000 | 0 | 0 | 2019-07-17T15:58:37.560000-04:00 | |
| 2308395 | BALCH & BINGHAM, LLP 73871046-3623-437c-af22-94df4242dd84 | Q2 | BALCH & BINGHAM, LLP | 5197 | TRANSCENDENCE, INC. | 2019 | second_quarter | MED | New medical innovations for improved treatment. | 0 | 0 | 2019-07-17T17:03:26.177000-04:00 | |||
| 2308665 | ATLAS ADVOCACY 901bc754-70e1-420d-a0c3-577dac390b1c | Q2 | ATLAS ADVOCACY | 401100069 | BLADDER CANCER ADVOCACY NETWORK | 2019 | second_quarter | MED | CDMRP; Disease Awreness resolution | HOUSE OF REPRESENTATIVES,SENATE | 9000 | 0 | 0 | 2019-07-17T21:00:52.133000-04:00 | |
| 2308670 | GOVERNMENT COUNSEL, LLC e2f58525-7475-473d-b7ef-d8da638e61f4 | Q2 | GOVERNMENT COUNSEL, LLC | 401105070 | HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) | 2019 | second_quarter | MED | The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2018 | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-07-17T21:14:53.887000-04:00 | |
| 2308867 | GREENBERG TRAURIG, LLP d47f504e-96d7-45cb-9a3d-83c4d318d301 | Q2 | GREENBERG TRAURIG, LLP | 16896 | AMERICAN SOCIETY INTERVENTIONAL PAIN PHYSICIANS | 2019 | second_quarter | MED | Outreach and monitoring related to the implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Outreach and monitoring related to federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Outreach and monitoring related to federal and legislative activity related to Medicare Reimbursement. Outreach and monitoring related to federal issues and legislation associated with health care policy. Outreach and monitoring related to federal issues and legislation associated with opioids. H.R. 3107 Improving Seniors Timely Access to Care Act of 2019 | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2019-07-18T09:35:11.967000-04:00 | |
| 2309075 | UNIVERSITY OF MIAMI f85e92c8-cf43-4335-8aaf-83f970144e39 | Q2 | UNIVERSITY OF MIAMI | 39462 | UNIVERSITY OF MIAMI | 2019 | second_quarter | MED | Fire Fighter Cancer | Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 62000 | 0 | 0 | 2019-07-18T10:12:33.847000-04:00 | |
| 2309101 | THORN RUN PARTNERS bbc5a69d-b9dc-4833-9651-6a0fdd70a32b | Q2 | THORN RUN PARTNERS | 400534596 | CONTINUING MEDICAL EDUCATION COALITION | 2019 | second_quarter | MED | Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act. Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10. Issues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS; Expressing the sense of Congress on the need to improve and expand training for future physicians on properly treating pain and prescribing opioids, and for other purposes (H.Con.Res.8). Policies to promote the use of continuing medical education to support greater physician understanding about biosimilars. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2019-07-18T10:16:40.910000-04:00 | |
| 2309459 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) a081aaf1-830c-49b0-bf4f-6f58b19db2ae | Q2 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 86196 | COLOR HEALTH (FKA COLOR GENOMICS) | 2019 | second_quarter | MED | Lobbying related to healthcare issues. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2019-07-18T11:07:50.417000-04:00 | |
| 2309554 | BIODESIX 49243b3a-c5dd-447e-a145-9ed45a579c38 | Q2 | BIODESIX | 401105286 | BIODESIX | 2019 | second_quarter | MED | -Regulation of laboratory developed tests (Verifying Accurate, Leading-edge IVCT Development (VALID) Act discussion draft) | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 58000 | 0 | 0 | 2019-07-18T11:22:27.557000-04:00 | |
| 2309628 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 5998680a-462b-49d7-8ce5-0a009c2e2c95 | Q2 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 86196 | INTUITIVE SURGICAL, INC. | 2019 | second_quarter | MED | Lobbying related to health care issues. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-07-18T11:34:51.507000-04:00 | |
| 2309751 | BALLARD PARTNERS 5c16994e-5584-41a7-926f-19d533c8a504 | Q2 | BALLARD PARTNERS | 401104288 | LABORATORY CORPORATIONS OF AMERICA HOLDINGS | 2019 | second_quarter | MED | Clinical Lab Rates | Health & Human Services, Dept of (HHS),White House Office | 80000 | 0 | 0 | 2019-07-18T12:13:44.560000-04:00 | |
| 2309827 | THE PETRIZZO GROUP, INC. a3f00942-5355-474d-a9c4-24631e0759ad | Q2 | THE PETRIZZO GROUP, INC. | 305932 | OMEROS CORPORATION | 2019 | second_quarter | MED | Advocated for Medicare Part B packaged payment reforms; and the expansion of the non-opioid pain management drug exclusion to the drugs functioning as supplies during a surgical procedure packaging policy. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE,Vice President of the U.S.,White House Office | 75000 | 0 | 0 | 2019-07-18T12:31:16.733000-04:00 | |
| 2309916 | THE PETRIZZO GROUP, INC. be028e35-838b-4a85-a0b4-76ac19e44d50 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION | 2019 | second_quarter | MED | Funding for NIH research; increased funding for sickle cell research | HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2019-07-18T12:56:47.627000-04:00 | |
| 2309932 | THE PETRIZZO GROUP, INC. 44703dfb-a457-4fe7-ab57-2b0b53eb6606 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | UNITED BIOMEDICAL, INC. | 2019 | second_quarter | MED | Advocated for federal funding and development of robust vaccine research for Alzheimer's, Parkinson's and other neurological diseases. | Agriculture, Dept of (USDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Mental Health (NIMH),Natl Institutes of Health (NIH),SENATE,White House Office | 50000 | 0 | 0 | 2019-07-18T13:01:53.767000-04:00 | |
| 2309991 | MGD STRATEGIES LLC e5af20f3-93a3-4a2a-8e4e-cbc5acf03ed2 | 2T | MGD STRATEGIES LLC | 401104776 | ESOPHAGEAL CANCER ACTION NETWORK (ECAN) | 2019 | second_quarter | MED | Report language in the Department of Defense Appropriations bills to include esophageal cancer in the Peer-Reviewed Cancer Research Program | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2019-07-18T13:11:16.800000-04:00 | |
| 2310106 | DLA PIPER LLP (US) e6de9598-be20-430f-8735-bfab296259b4 | Q2 | DLA PIPER LLP (US) | 76855 | PATIENT POCKET LLC | 2019 | second_quarter | MED | Issues related to operating room safety policies. H.R. 2745, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2020. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-07-18T13:39:01.663000-04:00 | |
| 2310207 | SQUIRE PATTON BOGGS 3ebd0522-88b2-42d6-b247-d9670c58c7fc | Q2 | SQUIRE PATTON BOGGS | 30906 | THOMAS JEFFERSON UNIVERSITY | 2019 | second_quarter | MED | Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2019-07-18T14:02:36.010000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);